About Us
Vivesto is a specialty pharmaceutical company focused on the development of new therapeutic options for patients suffering from hard-to-treat cancers.
-
Regulatory June 13, 2022Vivesto and CEO Francois Martelet have agreed on ending the employment relationship
-
Regulatory May 25, 2022Report from Annual General Meeting in Vivesto AB
-
Regulatory May 25, 2022Interim report for the period January 1, 2022 – March 31, 2022
Vivesto published its Q1 2022 report on May 25, 2022, at 08.00 am CET.